Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0013421 (
dystonia
)
8,418
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Currently, at least 12 types of
dystonia
can be distinguished on a genetic basis. Advances in the molecular genetics of
dystonia
have led to the recent identification of a 3-bp deletion in the DYT1 gene, causing early-onset generalized torsion dystonia (TD), and to the detection of mutations in the GTP cyclohydrolase I and the tyrosine hydroxylase genes causing dopa-responsive dystonia (DYT5). A missense change in the D2 dopamine receptor has been shown to be associated with myoclonus-
dystonia
in one family. In addition, six other
dystonia
gene loci have been mapped to chromosomal regions, including a locus for a mixed
dystonia
phenotype (DYT6), one form of focal
dystonia
(DYT7), two types of paroxysmal
dystonia
(DYT8,
DYT9
), X-linked
dystonia
-parkinsonism (DYT3), and rapid-onset
dystonia
parkinsonism (DYT12). No positive linkage studies have as yet been reported for autosomal recessive TD (DYT2) and in several other large families with various types of dominantly inherited TD (DYT4). It may be anticipated that the traditional clinical and etiological classifications of
dystonia
will increasingly be replaced by a genetic one and that the identification of more
dystonia
genes may lead to a better understanding of these largely nondegenerative disorders.
...
PMID:Genetics of primary dystonia. 1219 83
Presently, 17 distinct monogenic primary dystonias referred to as dystonias 1- 4, 5a,b, 6-8, 10-13 and 15-18 (loci DYT 1-4, 5a,b, 6-8, 10-13, 15-18) have been recognized. Twelve forms are inherited as autosomal dominant, four as autosomal recessive and one as an X-linked recessive trait. Three additional autosomal dominant forms (
DYT9
, DYT19 and DYT20) might exist based on linkage mapping to regions apparently different from, yet in close proximity to or overlapping with the known loci DYT18, DYT10 and DYT8. Clinically, this group of movement disorders includes pure dystonias and
dystonia
plus syndromes. In addition, dyskinesias (paroxysmal dystonias), although phenotypically distinct from classical dystonias, are discussed within this group. In pure dystonias,
dystonia
is occasionally accompanied by tremor. In
dystonia
plus syndromes,
dystonia
as the prominent sign concurs with other movement abnormalities such as myoclonus and parkinsonism. In the dyskinesias,
dystonia
occurs as a paroxysmal sign in association with other movement anomalies and sometimes seizures. While gross neuropathological changes are absent in most primary dystonias, including the paroxysmal forms, striking morphological alterations are found in some, such as in the X-linked
dystonia
-parkinsonism syndrome (DYT3). Neuropathological findings at the microscopic level have also been reported in several cases of
dystonia
1 and 5, both of which were previously thought to be morphologically normal. One locus, DYT14 had been erroneously assigned, by linkage mapping, in a family with
dystonia
5. There are two forms of
dystonia
5, one autosomal dominant and one autosomal recessive. These forms are designated here as
dystonia
5a and
dystonia
5b (DYT5a, DYT5b), respectively. The disease gene has been identified in 10 primary dystonias, seven autosomal dominant (TOR1A/DYT1, GCH1/DYT5a, THAP1/DYT6, PNKD1/MR-1/DYT8, SGCE/DYT11, ATP1A3/DYT12 and SLC2A1/DYT18), two autosomal recessive (TH/DYT5b and PRKRA/DYT16) and one X-chromosomal recessive (TAF1/DYT3). This article summarizes all known aspects on each of the monogenic primary dystonias, including phenotype, neuropathology, imaging, inheritance, mapping, molecular genetics, molecular pathology, animal models and treatment. Suggestions for the diagnostic procedure in primary dystonias are given. Although much is now known about the molecular basis of primary dystonias, treatment of patients is still mainly symptomatic. The only exceptions are dystonias 5a and 5b with their excellent long-term response to L-dopa substitution.
...
PMID:The monogenic primary dystonias. 1957 24
Primary monogenic forms of
dystonia
manifest solely or mainly with
dystonia
; they have been linked to a number of genes and loci and assigned "DYT" numbers. The pure
dystonia
syndrome early-onset primary
dystonia
(DYT1) manifests with dominantly-inherited generalized
dystonia
, often with focal onset in a limb. DYT1 is caused by a GAG deletion in the TOR1A gene. Mutations in the THAP1 gene cause DYT6, a form of pure
dystonia
that primarily involves cranio-cervical and upper limb muscles. Patients with the
dystonia
plus syndrome DYT5 display levodopa-responsive
dystonia
sometimes associated with tremor or parkinsonism (DYT5a, mutations in GCH1); a more severe phenotype with psychomotor involvement can be seen in recessive forms (DYT5b with TH mutations, SPR-deficiency syndrome). Other forms of
dystonia
plus syndromes include myoclonic
dystonia
(DYT11) and rapid-onset
dystonia
-parkinsonism (DYT12). Finally, paroxysmal exertion-induced
dystonia
(DYT18, GLUT1 deficiency) is caused by mutations in the SLC2A1 gene (
DYT9
and DYT18). It is part of the paroxysmal
dystonia
group and manifests with paroxystic movements sometimes associated with seizures and psychomotor developmental delay.
...
PMID:Overview of primary monogenic dystonia. 2216 20